Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iheezo vs Standard Anesthesia for Intravitreal Injections
NCT07779356Phase 4Completed
- Sponsor
- Retina Consultants of Delmarva
- Start
- May 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of chloroprocaine (2 arms), sponsored by Retina Consultants of Delmarva. Primary endpoint: Ocular Discomfort after injection at 24 hours. Started May 2026; status: completed.
02
Drugs
chloroprocaine
Beyond the preview
Go deeper on NCT07779356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07779356.